SR

Santosh Rani

Active Director Director DIN 09421209
DIN 09421209 First appointment Nov 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value •••• Premium profile

About Santosh Rani

Data last updated:

Santosh Rani is a Director at Medcure Organics Private Limited (since 2021). The company operates in Healthcare. Medcure Organics Private Limited reported revenue of ₹6.30 Cr (FY 2025).

DIN 09421209
Primary Designation Director
Industry Healthcare
First Appointment 29 Nov 2021
Oldest Company Age 16 yrs
Largest company Medcure Organics Private Limited · ₹6.30 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medcure Organics Private Limited U74900UP2010PTC042026
Director29 Nov 20212010₹6.30 Cr (FY 2025)Active

Board colleagues of Santosh Rani

Directorship timeline

Open interactive timeline →
Medcure Organics Private Limited
Premium access

Shareholding and investment profile for Santosh Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Santosh Rani

Santosh Rani currently holds 1 directorship: Medcure Organics Private Limited (Director, since 29 Nov 2021, revenue ₹6.30 Cr (FY 2025)).

Santosh Rani was first appointed on 29 Nov 2021 as Director at Medcure Organics Private Limited.

The current boards of Santosh Rani's companies include Shikha Jain (Medcure Organics Private Limited), Vasu Agarwal (Medcure Organics Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available